Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Editorial

  • 234 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 23
  • 24
  • Next →
Senator, what is your policy on . . . “Other”?
Laurence A. Turka
Laurence A. Turka
Published September 2, 2008
Citation Information: J Clin Invest. 2008;118(9):2988-2988. https://doi.org/10.1172/JCI37035.
View: Text | PDF

Senator, what is your policy on . . . “Other”?

  • Text
  • PDF
Abstract

In the midst of the monumentally important 2008 presidential election, information about the candidates’ proposals for biomedical research is notably absent. Why is this the case, and more importantly, what can be done about it?

Authors

Laurence A. Turka

×

Publish or perish, but at what cost?
Ushma S. Neill
Ushma S. Neill
Published July 1, 2008
Citation Information: J Clin Invest. 2008;118(7):2368-2368. https://doi.org/10.1172/JCI36371.
View: Text | PDF
Article has an altmetric score of 7

Publish or perish, but at what cost?

  • Text
  • PDF
Abstract

The academic scientific enterprise rewards those with the longest CVs and the most publications. Under pressure to generate voluminous output, scientists often fall prey to double publishing, self plagiarism, and submitting the “minimal publishable unit.” Are these ethical gray areas, or true transgressions?

Authors

Ushma S. Neill

×

Animal house
Laurence A. Turka
Laurence A. Turka
Published March 3, 2008
Citation Information: J Clin Invest. 2008;118(3):822-822. https://doi.org/10.1172/JCI35214.
View: Text | PDF

Animal house

  • Text
  • PDF
Abstract

While the JCI was originally conceived as a journal that would integrate various scientific approaches to the examination of human physiology and pathophysiology, we now find many of its pages filled with animal models of human disease. Is this a good thing?

Authors

Laurence A. Turka

×

A method to our madness
Laurence A. Turka
Laurence A. Turka
Published November 1, 2007
Citation Information: J Clin Invest. 2007;117(11):3144-3144. https://doi.org/10.1172/JCI34071.
View: Text | PDF

A method to our madness

  • Text
  • PDF
Abstract

Until recently, journal editorial operations and decisions seemed impenetrable to me. Now I have a view from the inside out.

Authors

Laurence A. Turka

×

Navigating through the gray (and CMYK) areas of figure manipulation: rules at the JCI
Ushma Neill, Laurence A. Turka
Ushma Neill, Laurence A. Turka
Published October 1, 2007
Citation Information: J Clin Invest. 2007;117(10):2736-2736. https://doi.org/10.1172/JCI33829.
View: Text | PDF

Navigating through the gray (and CMYK) areas of figure manipulation: rules at the JCI

  • Text
  • PDF
Abstract

Since it seems many of the articles we’re accepting continue to have image rearrangements and changes in them that are not consistent with JCI policy, we thought it might be a good idea to spell out exactly what is, and more importantly what isn’t, allowed.

Authors

Ushma Neill, Laurence A. Turka

×

Lost in a dark wood
Laurence A Turka
Laurence A Turka
Published July 2, 2007
Citation Information: J Clin Invest. 2007;117(7):1734-1735. https://doi.org/10.1172/JCI32797.
View: Text | PDF

Lost in a dark wood

  • Text
  • PDF
Abstract

Authors

Laurence A Turka

×

Evolution, not revolution
Laurence A. Turka
Laurence A. Turka
Published March 1, 2007
Citation Information: J Clin Invest. 2007;117(3):504-505. https://doi.org/10.1172/JCI31465.
View: Text | PDF

Evolution, not revolution

  • Text
  • PDF
Abstract

A new sheriff is in town: as of March 1, 2007, the editorial board of the JCI will be based at the University of Pennsylvania. While our core mission to provide the best venue for biomedical research remains the same, we plan a number of refinements that we hope will benefit our readers, authors, and referees.

Authors

Laurence A. Turka

×

A new JCI conflict-of-interest policy
Ushma S. Neill, … , Marc Feldmann, William N. Kelley
Ushma S. Neill, … , Marc Feldmann, William N. Kelley
Published March 1, 2007
Citation Information: J Clin Invest. 2007;117(3):506-508. https://doi.org/10.1172/JCI31587.
View: Text | PDF
Article has an altmetric score of 6

A new JCI conflict-of-interest policy

  • Text
  • PDF
Abstract

As stewards of the JCI, we are responsible for instituting and sustaining the highest possible standards for integrity. To this end, we have established a very specific set of guidelines for handling potential conflicts of interest — not only for authors and referees, but also for ourselves.

Authors

Ushma S. Neill, Craig B. Thompson, Marc Feldmann, William N. Kelley

×

Hello, goodbye
Andrew R. Marks
Andrew R. Marks
Published February 1, 2007
Citation Information: J Clin Invest. 2007;117(2):280-281. https://doi.org/10.1172/JCI31214.
View: Text | PDF

Hello, goodbye

  • Text
  • PDF
Abstract

Much has changed in the 5 years since the responsibility for editing the JCI was transferred to Columbia University. Wars and a hurricane have conspired with other factors to overwhelm the national treasury. Support for investigator-initiated research at the NIH is now at a level that jeopardizes the nation’s ability to adequately train future scientists to maintain the country’s leadership in biomedical research. Indeed, there is insufficient support for even the best and brightest biomedical scientists to pursue the frontiers of the sciences at a time of unprecedented opportunities. Human embryonic stem cell research is still being suppressed in the United States. Economic models that enable academic health centers to flourish in the face of increasing challenges and the rising costs of health care have for the most part remained elusive. Translational research has become the buzzword, but there is widespread confusion and disagreement about how to do it. Despite all of these and other challenges to the biomedical research enterprise, the JCI remains vibrant, with record numbers of submissions and a loyal and enthusiastic readership.

Authors

Andrew R. Marks

×

Physician-scientist, heal thyself . . .
Andrew R. Marks
Andrew R. Marks
Published January 2, 2007
Citation Information: J Clin Invest. 2007;117(1):2-2. https://doi.org/10.1172/JCI31031.
View: Text | PDF

Physician-scientist, heal thyself . . .

  • Text
  • PDF
Abstract

Historically, physician-scientists have had dual roles in caring for patients and in performing investigative research that could potentially lead to new diagnostics and therapeutics. Physician-scientists conducted teaching rounds in the hospital, surrounded by eager house staff and medical students, and were often avidly pursued as the most important sources of new knowledge for trainees. But alas, times have changed. Now physician-scientists are rarely seen in the hospital; they are most often spotted at their desks tapping out yet another grant application. Most struggle to find the time to mentor students and clinical trainees, let alone to care for patients in the hospital, even though these interactions are often the motivating forces for scientific creativity.

Authors

Andrew R. Marks

×
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 23
  • 24
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 3 X users
Referenced in 11 Wikipedia pages
On 1 videos
128 readers on Mendeley
See more details
Blogged by 1
3 readers on Mendeley
See more details